Compound’s decline is having a hard time making it past the $195 price point. This may be the entry point, though I would like to see it provide us with a little longer path to profit.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.